eove EO-70 - Adverse Effects; Contraindications; Definitions; Indications for Use

6
Introduction
The EO-70 (ref EO70) Secretion Management Device (SMD) provides treatment for patients not able
to manage their secretions on their own. It provides Insufflation – Exsufflation (INEX) and
Intermittent Positive Pressure Breathing (IPPB) modes for adult and pediatric patients as prescribed
by an attending doctor.
Indications for use
The EO-70 Secretion Management Device provides treatment support for pediatric and adult
patients weighting at least 5 kg (11 lbs) who requires secretion management support. The EO-70
device is intended to be used in home, institution, hospital for both invasive and non-invasive
interface. This device is transportable but not intended for use during transport.
The EO-70 device may be used either with a mask, mouthpiece or tracheostomy tube.
WARNING

E0VE 70 is not for use with anaesthetic gases.

E0VE 70 is not for use in an oxygen enriched environment.

Do not use EO-70 device in an MRI equipment or in a barotherapy equipment
Contraindications
 Barotrauma
 Pneumothorax
 Pneumomediastinum
 Bullous emphysema
Adverse Effects
 Dry nose or mouth
 Eye irritation
 Bloating
 Gastric distension
 Skin wound
 Sinus discomfort
Definitions
WARNING
Indicates
a condition that may endanger the patient or the device operator
CAUTION
Indicates a condition that may damage the device or equipment
NOTE
:
Advice that makes operation of the device more
convenient or efficient